Cargando…
Association between genetic polymorphisms and platinum-induced ototoxicity in children
Platinum is extensively used in the treatment of several childhood cancers. However, ototoxicity is one of the most notable adverse effects, especially in children. Several studies suggest that genetics may predict its occurrence. Here, polymorphisms associated with platinum-induced ototoxicity were...
Autores principales: | Lui, Gabrielle, Bouazza, Naïm, Denoyelle, Françoise, Moine, Marion, Brugières, Laurence, Chastagner, Pascal, Corradini, Nadège, Entz-Werle, Natacha, Vérité, Cécile, Landmanparker, Judith, Sudour-Bonnange, Hélène, Pasquet, Marlène, Verschuur, Arnauld, Faure-Conter, Cécile, Doz, François, Tréluyer, Jean-Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089394/ https://www.ncbi.nlm.nih.gov/pubmed/30112115 http://dx.doi.org/10.18632/oncotarget.25767 |
Ejemplares similares
-
Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol
por: Winnicki, Camille, et al.
Publicado: (2023) -
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
por: Verschuur, Arnauld, et al.
Publicado: (2018) -
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
por: Leblond, Pierre, et al.
Publicado: (2023) -
EPCT-11. PHASE 1 STUDY OF FLUVASTATIN-CELECOXIB COMBINATION IN CHILDREN WITH RELAPSING/REFRACTORY OPTICO-CHIASMATIC LOW-GRADE GLIOMA OR HIGH-GRADE GLIOMAS (FLUVABREX): FINAL RESULTS
por: Andrew, Nicolas, et al.
Publicado: (2020) -
Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study
por: Chappuy, Hélène, et al.
Publicado: (2013)